VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]
Partnership further validates Ethris’ novel technology platform based on stabilized [...]
The International Finance Facility for Immunisation (IFFIm) today announced the [...]
VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]
Partnership further validates Ethris’ novel technology platform based on stabilized [...]
The International Finance Facility for Immunisation (IFFIm) today announced the [...]